Ocular Surgery News

09/11/2026

The granted priority review to a supplemental biologics license application for .

The application covers treatment of myelin oligodendrocyte glycoprotein antibody-associated disease, a rare autoimmune disease.

Find out more:🔗

https://vist.ly/5i5wr

Roche

The FDA granted priority review to a supplemental biologics license application for Enspryng for myelin oligodendrocyte glycoprotein antibody-associated disease, according to a press release from Roche.“Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmun...

09/11/2026

Need the right ICD-10 code? Ask Healio AI. Get quick answers to coding questions without digging through lengthy code lists. Try a sample prompt and see how it works 👉 https://vist.ly/5i5q4

09/11/2026

Flashback to 👀

size may have a clinically meaningful impact on final IOL positioning after robotic laser .

Find out more on Healio: 🔗

https://vist.ly/5i3yq

09/10/2026

Healthy aging is all about staying active, curious and engaged. 🧠 Give your brain a quick workout with WORD DOC and get your streak going.

Play now: https://vist.ly/5h2db

09/10/2026

Identifying can’t-miss findings in is essential for comprehensive . 👀

Several red flags 🚩should prompt a workup or referral.

Read the latest blog from Paul B. Johnson, MD, on Healio: 🔗

Most lid conditions are exactly what they appear to be — age-related dermatochalasis, aponeurotic ptosis or a routine chalazion.However, every oculoplastic surgeon has seen the patient whose serious diagnosis was masquerading as a much more benign complaint.

09/10/2026

👓 Ready to refine your RVO treatment approach? This case-based CME activity delivers practical insights

Start Now: https://bit.ly/4bVMPvt

09/10/2026

A 22-year-old woman presents with 7 years of bilateral blurry .

4️⃣ were unable to correct her visual acuity to better than 20/40.

Crack the case with Healio: 🔗

A 22-year-old woman of East Asian descent was referred to Tufts Medical Center for bilateral blurry vision over the past 7 years.She had seen four different optometrists over the past year who were unable to correct her visual acuity to better than 20/40. Given a lack of explanation for why her visi...

09/10/2026

Missed out on 2026? No worries, we’ve got you covered. Check out the meeting news here: https://vist.ly/5hxcr

Healio is an Official Media Partner of the Women in Ophthalmology Summer Symposium.

09/10/2026

The accepted a biologics license application for Mogenry from Nanoscope Therapeutics.

Mogenry is a one-time intravitreal optogenetic for .

Read more on Healio: 🔗

The FDA accepted a biologics license application for Mogenry, Nanoscope Therapeutics’ investigational therapy designed for vision restoration in retinitis pigmentosa, according to a press release.

09/09/2026

According to an analysis presented at on -based screening:

“This suggests that health system-only analyses may underestimate the true value of AI-based screening.”

More on Healio:🔗

MONTEREY, Calif. — Alongside improved clinical efficiency and follow-up adherence, AI-based diabetic retinopathy screening yielded positive reductions in cost for patients, according to a poster presentation. The study, presented at the Women in Ophthalmology Summer Symposium, aimed to measure the...